Related Experiment Video
Updated: May 1, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Change in functional selectivity of morphine with the development of antinociceptive tolerance
T A Macey1, E N Bobeck, K L Suchland
1Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.
Background And Purpose:
Opioids, such as morphine, are the most effective treatment for pain but their efficacy is diminished with the development of tolerance following repeated administration. Recently, we found that morphine activated ERK in opioid-tolerant but not in naïve rats, suggesting that morphine activation of μ-opioid receptors is altered following repeated morphine administration. Here, we have tested the hypothesis that μ-opioid receptor activation of ERK in the ventrolateral periaqueductal gray (vlPAG) is dependent on dynamin, a protein implicated in receptor endocytosis.
Experimental Approach:
Rats were made tolerant to repeated microinjections of morphine into the vlPAG. The effects of dynamin on ERK activation and antinociception were assessed by microinjecting myristoylated dominant-negative dynamin peptide (Dyn-DN) or a scrambled control peptide into the vlPAG. Microinjection of a fluorescent dermorphin analogue (DERM-A594) into the vlPAG was used to monitor μ-opioid receptor internalization.
Key Results:
Morphine did not activate ERK and Dyn-DN administration had no effect on morphine-induced antinociception in saline-pretreated rats. In contrast, morphine-induced ERK activation in morphine-pretreated rats that was blocked by Dyn-DN administration. Dyn-DN also inhibited morphine antinociception. Finally, morphine reduced DERM-A594 internalization only in morphine-tolerant rats indicating that μ-opioid receptors were internalized and unavailable to bind DERM-A594.
Conclusions And Implications:
Repeated morphine administration increased μ-opioid receptor activation of ERK signalling via a dynamin-dependent mechanism. These results demonstrate that the balance of agonist signalling to G-protein and dynamin-dependent pathways is altered, effectively changing the functional selectivity of the agonist-receptor complex.
Linked Articles:
This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.
Insights
Repeated morphine use alters μ-opioid receptor signaling, leading to tolerance. Dynamin-dependent receptor internalization reduces pain relief by affecting ERK activation.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Opioids are effective analgesics but tolerance diminishes their efficacy.
- Morphine activates ERK in tolerant rats, suggesting altered receptor signaling.
- μ-opioid receptor (MOR) activation of ERK may involve dynamin-dependent endocytosis.
Purpose of the Study:
- To test if MOR activation of ERK in the ventrolateral periaqueductal gray (vlPAG) depends on dynamin.
- To investigate the role of dynamin in morphine tolerance and antinociception.
Main Methods:
- Rats were rendered tolerant to morphine via vlPAG microinjections.
- Dynamin's role was assessed using a dominant-negative dynamin peptide (Dyn-DN).
- μ-opioid receptor internalization was monitored using a fluorescent dermorphin analogue (DERM-A594).
Main Results:
- Morphine did not activate ERK in naïve rats; Dyn-DN had no effect.
- In tolerant rats, Dyn-DN blocked morphine-induced ERK activation and inhibited antinociception.
- Morphine reduced DERM-A594 internalization in tolerant rats, indicating receptor unavailability.
Conclusions:
- Repeated morphine administration enhances MOR-ERK signaling through a dynamin-dependent pathway.
- This suggests altered functional selectivity of the MOR complex, favoring G-protein over dynamin-dependent signaling.
- Dynamin-mediated receptor internalization contributes to opioid tolerance.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Nociception
Desensitization and Tachyphylaxis

